Psyomics
- Company typePrivate
- Founded2015
- HeadquartersCambridge, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
Psyomics firmographics
Firmographics- Name
- Psyomics
- Legal name
- Psyomics Ltd
- Website
- https://psyomics.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Psyomics industry classification
Industry- Product category
- Mental Health Assessment Software
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Prepackaged Software (7372), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ)
- akta.pro secondary industry
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)
Keywords
Where Psyomics is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Markets served
Psyomics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: B2B SaaS platform providing mental health and neurodiversity assessment tools to healthcare providers including NHS Trusts, with subscription-based licensing model. The platform is sold through enterprise sales motion with discovery, proposal, implementation, and ongoing support phases.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Psyomics product offering
Product offeringCore offering
Psyomics sells AI-driven digital health assessment software (beseen and Censeo platforms) to healthcare providers for behavioral health and neurodiversity screening in adult, children and young people, and ADHD/autism pathways. The offering is delivered as a B2B SaaS subscription with EPR/EHR integration, implementation, and go-live support, and is augmented by an in-development dry blood spot Bipolar Biomarker test that combines metabolomic data with online questionnaires via machine learning.
Product overview
Psyomics offers a suite of digital health products centered on the beseen platform, which provides integrated digital automation for behavioral health assessments. The platform includes specialized modules for Adult services (beseen Adult) and Young People services (beseen Young People), as well as a neurodiversity module (beseen for neurodiversity) covering ADHD and autism assessments. The company also offers the Censeo AI-driven mental health platform in partnership with clinical providers, and is developing a Bipolar Biomarker test that uses biological markers combined with digital analysis to differentiate between depressive disorders.
Differentiator
Problem solved
Functional benefit
Brands
- beseen: Digital platform for neurodiversity covering ADHD, autism, and dual assessments for adults and young people. Developed in collaboration with NHS trusts to help manage neurodevelopmental referral backlogs.
- beseen young people
- Bipolar Biomarker
Products and services
- beseen AI-driven digital health platform for behavioral health and neurodiversity assessments that streamlines clinical workflows and reduces administrative burden across adult and young people populations.
- beseen Adult Integrated digital automation solution for adult behavioral health assessments, delivering structured data and free text reports wherever needed in the care pathway.
- beseen Young People Assessment platform for children and young people combining inputs from children, families, and professionals into one structured report for integrated care from the first contact.
- beseen for neurodiversity Digital platform for ADHD, autism, and dual assessments for adults and young people, designed to manage neurodevelopmental referral backlogs across NHS Trusts, Integrated Care Boards, and regional networks.
- Censeo AI-driven mental health platform deployed at UK clinical locations in partnership with the Priory Group, focusing on reducing waiting times and improving assessment quality.
- Bipolar Biomarker Dry blood spot test combined with machine learning algorithms to differentiate between Major Depressive Disorder and Bipolar disorder, aiming to reduce misdiagnosis.
Quantifiable outcome
- 78% patient assessment completion rate
- +5 more outcomes
Companies that use Psyomics
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles3 records
Psyomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
Psyomics partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Midlands Partnership University NHS Foundation TrustcoreCollaborative development of beseen platform for neurodiversity covering ADHD, autism, and dual assessments. The platform helps NHS services manage rising neurodevelopmental referral backlogs, with early modelling showing potential 30% reduction in clinical time.
- North London NHS Foundation TrustcorePartnership to enhance mental health care access across several London boroughs serving over 1.6 million residents, as part of a broader transformation programme to improve care and streamline referrals.
- Priory GroupcorePriory Group partnered with Psyomics to deploy its AI-driven Censeo platform at UK clinical locations, enabling improved mental health assessment capabilities across Priory's clinical network.
Scale indicators11 records
Recent moves6 records
Expansion highlights6 records
Psyomics competitors and assessment
Company assessmentDirect peers
- Limbic: UK-based AI-driven mental health platform offering NHS-facing digital triage, self-referral and assessment tools. Highly comparable to Psyomics' Censeo/beseen offering in terms of NHS GTM, AI-based patient intake, and focus on reducing waiting lists.
- Qbtech: Provides QbTest, an FDA-cleared objective ADHD assessment combining continuous performance test data with clinical information. Directly comparable to Psyomics' beseen for neurodiversity ADHD assessment offering in clinical positioning and NHS deployment.
- Akili Interactive: Digital therapeutics company with FDA-cleared products (EndeavorRx) for ADHD and cognitive conditions. Comparable to Psyomics in combining software-based cognitive/behavioral assessment and intervention for neurodiversity populations.
- Altoida: Digital biomarker company using AI/ML on smartphone-based cognitive assessments for early detection of neurological conditions. Directly comparable to Psyomics in the digital biomarker / SaMD evidence-generation pathway for neuropsychiatric conditions.
- Cambridge Cognition: UK-based digital cognitive assessment company selling into clinical trials, NHS and pharma. Highly comparable in Cambridge roots, NHS-aligned cognitive/behavioral assessment products, and focus on digital endpoints for CNS conditions.
- P1vital: UK CNS-focused company developing biomarkers, digital health tools and clinical trial services for depression, anxiety and cognition. Closely comparable to Psyomics' bipolar biomarker and CNS diagnostic strategy, particularly the metabolomic/biological diagnostic angle.
- Linus Health: Digital cognitive assessment platform using AI on speech and tablet-based tests to detect early cognitive impairment. Comparable to Psyomics in the digital biomarker / AI assessment space and in targeting primary care and clinical decision support.
Broad incumbents
- SilverCloud Health (Amwell): Digital mental health platform offering CBT-based therapeutic programs, now part of Amwell. Comparable as an established NHS-deployed digital mental health SaaS provider, though its focus is on therapeutic content rather than assessment and triage.
Regional players
- Cera Care: Large UK digital home healthcare provider using technology-enabled care services. Comparable as a UK digital health platform selling into NHS Trusts and integrated care systems with measurable efficiency outcomes.
- Doctor Care Anywhere: UK-based digital health platform providing virtual consultations and mental health services. Comparable as a UK private/regulated digital health operator with NHS-facing relationships and enterprise distribution motion.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Psyomics social profiles
Digital presencePsyomics compliance and trust
Trust signalCompliance2 records
Psyomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Psyomics leadership team
Management profileNumber of profiles
Profiles4 records
Psyomics funding detail
Funding detailFunding overview
Funding rounds9 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Psyomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Psyomics
What does Psyomics do?
Psyomics sells AI-driven digital health assessment software (beseen and Censeo platforms) to healthcare providers for behavioral health and neurodiversity screening in adult, children and young people, and ADHD/autism pathways. The offering is delivered as a B2B SaaS subscription with EPR/EHR integration, implementation, and go-live support, and is augmented by an in-development dry blood spot Bipolar Biomarker test that combines metabolomic data with online questionnaires via machine learning.
Is Psyomics a public or private company?
Psyomics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Psyomics founded?
Psyomics was founded in 2015. It employs 11 to 50 people.
Where is Psyomics based?
Psyomics is headquartered in Cambridge, United Kingdom, in the Europe region.
How does Psyomics make money?
One revenue line is on record: saaS Platform Subscription.
Who are Psyomics's main competitors?
Direct peers on record are Limbic, Qbtech, Akili Interactive, Altoida, Cambridge Cognition, P1vital and Linus Health. SilverCloud Health (Amwell) is listed as a broad incumbent. Regional players are Cera Care and Doctor Care Anywhere.
Does Psyomics have an API?
No public API is recorded for Psyomics.
What industry is Psyomics in?
Psyomics's product category is Mental Health Assessment Software. Its primary akta.pro industry code is HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 621511 and its SIC code is 7372.